Management Team

As one of the main pillars of healthcare systems, the pharmaceutical industry plays a key role in the supply, development, production, and distribution of medicines required by communities. Globally, the activities of this industry directly contribute to patients’ access to effective treatment, the quality of medical care, disease prevention, and the promotion of public health. Although, on average, 10% of countries’ gross domestic product is spent on healthcare, 15% of this share is allocated to medicines. Therefore, the importance of medicines to public health has placed the pharmaceutical industry at the forefront of medical research, with some major pharmaceutical companies today allocating as much as 50% of their revenues to research and development for the discovery and production of new medicines, as well as clinical trials for the treatment of complex and emerging diseases.

This research is particularly evident in the following areas:

• Vaccine development (such as COVID-19 vaccines and innovative cancer treatments).
• Development of advanced drug delivery methods and smart formulations.
• Production of biotechnology drugs (Biotech Drugs).

The pharmaceutical industry not only contributes to drug discovery but also works directly and indirectly to make an impact in the following social areas:

• Improving drug quality and patient safety.
• Reducing treatment costs and increasing public access to medicines.
• Supporting public health during crises.
• Creating employment and promoting economic development in the healthcare sector.

Raha Pharmaceutical Company was established in early 2003 by a group of experienced Iranian pharmacists and professors in the field, in response to the transformation that has taken place in the global pharmaceutical industry as well as Iran’s pharmaceutical industry over the past decades. With the motto of Research, Technology, and Innovation, the company has focused much of its activities on advanced Oral Drug Delivery Systems to achieve greater patient satisfaction. These systems enable controlled and precise drug release in the body, resulting in greater therapeutic efficacy and fewer adverse effects.

Fortunately, with this approach, the company has successfully developed and introduced to the market more than 20 extended-release oral pharmaceutical products that had no previous production history in the country, through the dedication of its committed researchers and scientists. For this reason, the company has been recognized by the Innovation and Prosperity Fund as one of the leading knowledge-based companies in the healthcare sector.

We believe that social responsibility, transparency in our performance, and commitment to the health and lives of patients are the cornerstones of public trust. This trust has always been, and will continue to be, a valuable asset to us. We sincerely appreciate the support of all physicians and pharmacists who guide us through their valuable suggestions. We hope that through continuous research and dedicated efforts, we can make an even greater contribution to improving public health.